ClearPoint System (Software Version 2.2) is an AI-enabled medical device from ClearPoint Neuro Inc., listed by FDA (510(k), K233243) with a decision date of 2023-11-27. Review panel: Neurology.
| FDA submission number | K233243 |
|---|---|
| Pathway | 510(k) |
| Company | ClearPoint Neuro Inc. |
| Review panel (specialty) | Neurology |
| FDA decision date | 2023-11-27 |
| Decision | Substantially Equivalent |
| Product code | HAW |
| Classification | Neurological Stereotaxic Instrument |
| Device class | 2 |
| Regulation number | 882.4560 |
| Review time (calendar days) | 60 |
| Applicant country | US |
Official FDA database record · FDA AI-enabled device list
More devices from ClearPoint Neuro Inc. · All Neurology AI devices · Full device index
Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.